Financhill
Buy
52

TERN Quote, Financials, Valuation and Earnings

Last price:
$42.02
Seasonality move :
-22.3%
Day range:
$40.52 - $42.88
52-week range:
$1.87 - $48.26
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
13.33x
Volume:
1.8M
Avg. volume:
2M
1-year change:
1039.02%
Market cap:
$3.8B
Revenue:
--
EPS (TTM):
-$1.03

Earnings Data

Next earnings date for TERN
Mar 19
2026
Most recent earnings per share
-$0.27
Beat by $0.03
(Nov 10/2025)
Consensus Estimate
-$0.30
(Nov 10/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TERN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 -- -- -- -$0.29 --
03/19/2026 Q4 -- -- -- -$0.29 --
11/10/2025 Q3 -- -- -$0.27 -$0.30 $0.03
08/05/2025 Q2 -- -- -$0.26 -$0.29 $0.02
05/08/2025 Q1 -- -- -$0.26 -$0.27 $0.01
03/20/2025 Q4 -- -- -$0.24 -$0.30 $0.06
11/12/2024 Q3 -- -- -$0.28 -$0.32 $0.04
08/05/2024 Q2 -- -- -$0.31 -$0.34 $0.03
05/13/2024 Q1 -- -- -$0.30 -$0.35 $0.04
03/14/2024 Q4 -- -- -$0.29 -$0.29 $0.00
11/14/2023 Q3 -- -- -$0.42 -- --
08/08/2023 Q2 -- -- -$0.25 -- --
05/15/2023 Q1 -- -- -$0.31 -- --
03/27/2023 Q4 -- -- -$0.29 -- --
11/09/2022 Q3 -- -- -$0.44 -- --
08/08/2022 Q2 -- -- -$0.55 -- --
05/16/2022 Q1 -- -- -$0.55 -- --
03/03/2022 Q4 -- $1M -$0.56 -- --
11/15/2021 Q3 -- -- -$0.47 -- --
08/16/2021 Q2 -- -- -$0.43 -- --
05/14/2021 Q1 -- -- -$0.53 -- --
12/31/2020 Q4 -- -- $0.03 -- --
09/30/2020 Q3 -- -- -$0.46 -- --
06/30/2020 Q2 -- -- -$0.39 -- --
03/31/2020 Q1 -- -- -$0.36 -- --
12/31/2019 Q4 -- -- -$0.39 -- --

Terns Pharmaceuticals, Inc. Earnings Questions

  • How Much did Terns Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Terns Pharmaceuticals, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Terns Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Terns Pharmaceuticals, Inc. announced earnings per share of -$0.27 which represents a beat of analyst forecast a -$0.30 per share.

  • Is Terns Pharmaceuticals, Inc. Profitable?

    Terns Pharmaceuticals, Inc. reported -$111K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Terns Pharmaceuticals, Inc. EPS Next Year?

    Terns Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$1.12 per share to -$1.08 per share next year representing a decrease of -10.96%.

  • When is Terns Pharmaceuticals, Inc.'s Earnings Date?

    Terns Pharmaceuticals, Inc.'s next earnings date is March 19, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
49
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 37x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
37
Is GOOGL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Sell
50
AXTI alert for Mar 3

AXT, Inc. [AXTI] is up 22.11% over the past day.

Buy
53
AAOI alert for Mar 3

Applied Optoelectronics, Inc. [AAOI] is up 21.71% over the past day.

Sell
32
TPB alert for Mar 3

Turning Point Brands, Inc. [TPB] is down 20.87% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock